Gen therapy

30th Sep 2026

Published in PharmaTimes magazine -
The clinical trials industry is embracing next-gen FSP models

For years, the functional service provider (FSP) model has given sponsors a practical way to extend internal teams and access specialist capabilities. What began primarily as a tactical resourcing model has become an established component of clinical development outsourcing.

However, the environment in which FSP models operate has changed significantly. Clinical development portfolios are increasingly complex and dynamic, workloads can shift rapidly and regulatory expectations continue to evolve.

At the same time, sponsors face sustained pressure to improve operational efficiency, maintain quality and accelerate development timelines. In this environment, a model based primarily on linear resource scaling is no longer sufficient.

Check out the rest of the feature here

PharmaTimes Magazine

Tags